{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-24-073396","form_type":"8-K","ticker":"APRE","cik":"0001781983","company_name":"Aprea Therapeutics, Inc.","filed_at":"2024-06-20T23:59:59+00:00","discovered_at":"2026-05-14T18:03:20.067597+00:00","generated_at":"2026-06-01T03:37:08.458837+00:00","sec_items":["5.07"],"event_type":"other","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"high","headline":"Aprea Therapeutics stockholders elect three Class II directors, ratify EisnerAmper as auditor","bullets":["Quorum of 70.46% represented at June 20, 2024 annual meeting.","Michael Grissinger, Gabriela Gruia, Rifat Pamukcu elected as Class II directors with >3M votes each vs. ~55K withheld.","Ratification of EisnerAmper LLP as auditor approved: 3,788,888 for, 7,750 against, 29,541 abstain.","Broker non-votes of 719,524 on director elections; none on ratification."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-24-073396","json":"https://secwatch.observer/filing/0001104659-24-073396.json","markdown":"https://secwatch.observer/filing/0001104659-24-073396.md","text":"https://secwatch.observer/filing/0001104659-24-073396.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1781983/000110465924073396/0001104659-24-073396-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1781983/000110465924073396/tm2417690d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T03:37:08.458837+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}